Botulinum toxin A (Lipella Pharmaceuticals)

A型肉毒毒素（Lipella Pharmaceuticals）

Report date: 2022/09/14 16:44:14

Base Information

Drug NameBotulinum toxin A (Lipella Pharmaceuticals)
Drug Alias NameLipotoxinLP-09
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsUrinary Bladder, OveractiveCystitis, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLipella Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLipella Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, OveractiveCystitis, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia